Status: current, Primitive. Date: 31-Jul 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3308594018 | Reslizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3308595017 | Reslizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Reslizumab | Is a | Interleukin 5 receptor antagonist | true | Inferred relationship | Some | ||
| Reslizumab | Has disposition | Interleukin 5 receptor antagonist | true | Inferred relationship | Some | ||
| Reslizumab | Is a | Respiratory system agent | true | Inferred relationship | Some | ||
| Reslizumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Reslizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Reslizumab only product in parenteral dose form | Has active ingredient | True | Reslizumab | Inferred relationship | Some | 1 |
| Reslizumab-containing product | Has active ingredient | True | Reslizumab | Inferred relationship | Some | 1 |
| Reslizumab only product | Has active ingredient | True | Reslizumab | Inferred relationship | Some | 1 |
| Reslizumab-containing product in parenteral dose form | Has active ingredient | True | Reslizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR